基于"互联网+CDQI房颤专病项目-West China百县工程"管理模式下彭州地区心房颤动患者的治疗效果研究

Research on the therapeutic effect of patients with atrial fibrillation in Pengzhou area based on the management mode of"Internet+CDQI atrial fibrillation specialty project-West China Hundred County Project"

目的 本研究旨在评估基于"互联网+CDQI房颤专病项目-West China百县工程"管理模式在彭州地区对心房颤动患者的治疗效果.方法 研究对象为2020年12月-2022年12月在彭州市人民医院及房颤联盟基层医联体医院就诊的心房颤动患者.对比项目启动前(非专病管理组)和项目启动后(专病管理组)两组患者在药物使用和治疗效果上的差异.结果 专病管理组在控制心室率药物、β受体阻滞剂、地高辛和胺碘酮的使用比例上显著低于非专病管理组,且在优化药物使用和提升治疗效果方面具有明显优势.此外,两组在口服抗凝药、抗血小板药物、抗凝及抗血小板药物的使用情况上也进行了对比分析.结论 专病管理模式在优化药物使用以及提升治疗效果方面展现出了较大的潜力.

Objective This study aims to evaluate the treatment outcomes of atrial fibrillation(AF)patients in Pengzhou under the"Internet+CDQI AF Specific Project-West China Hundred County Project"management model.Methods The study subjects were AF patients who visited Pengzhou People's Hospital and affiliated primary hospitals from December 2020 to December 2022.We compared the differences in drug use and treatment outcomes between the pre-project(non-specific management group)and post-project(specific management group)patients.Results The specific management group had significantly lower usage rates of rate-control drugs,β-blockers,digoxin,and amiodarone compared to the non-specific management group,indicating a significant advantage in optimizing drug use and improving treatment outcomes.Additionally,comparisons were made on the usage of oral anticoagulants,antiplatelet drugs,and combined anticoagulant and antiplatelet therapies between the two groups.Conclusion The specific management model demonstrated substantial potential in optimizing medication use and enhancing treatment effectiveness.